<DOC>
	<DOCNO>NCT00057473</DOCNO>
	<brief_summary>This clinical research study conduct investigate effectiveness combine carboplatin irinotecan , versus irinotecan alone , treat child refractory solid tumor .</brief_summary>
	<brief_title>A Phase II Study Carboplatin Plus Irinotecan Versus Irinotecan Children With Refractory Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>child 121 year age confirm diagnosis measurable solid tumor , include brain tumor , progressed standard therapy , effective standard therapy know least 4 week since last dose immunotherapy , radiotherapy , chemotherapy 3 prior chemotherapy symptomatic brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
</DOC>